briefingcom Posted - 3 days ago

$LH: Labcorp Holdings Inc. CFO Glenn Eisenberg announces plans to retire https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20241119070538LH&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

Thestocktraderhubzee Posted - 3 days ago

$LH Labcorp Announced That Executive Vice President And CFO Glenn Eisenberg Will Retire From The Company And Julia Wang Will Join On December 2 As Executive Vice President And CFO

swingingtech Posted - 4 days ago

$USCL $DELL $ALB $LH https://wallstreetwaves.com/surprising-analyst-12-month-target-for-uscl/

Seanwishwise Posted - 1 week ago

$TTOO in oversold zone. Anticipating a potential rebound. Collaboration with prxcision may help in enhancing diagnostic capabilities. $DGX $LH $TMO $ABT

TheTradeXchange Posted - 2 weeks ago

$LH - Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience

TheTradeXchange Posted - 2 weeks ago

$LH Praia Health Secures Strategic Investment from Labcorp Venture Fund, Announces New Collaboration to Streamline Patient Lab Ordering Experience

smartkarma Posted - 3 weeks ago

$LH | Laboratory Corporation of America Holdings (LabCorp): Advancement in Oncology Diagnostics & Other Major Highlights Of Q3 That Could Have A Long Term Impact! - Financial Forecasts "Labcorp Holdings has posted its financial results for the third quarter of 2024, reflecting robust growth and operational advancements, although..." - Baptista Research (Baptista Research) Read more: https://www.smartkarma.com/insights/laboratory-corporation-of-america-holdings-labcorp-advancement-in-oncology-diagnostics-other-major-highlights-of-q3-that-could-have-a-long-term-impact-financial-forecasts

insiderbuyingselling Posted - 10/25/24

$LH new insider selling: 1000 shares. http://insiderbuyingselling.com/?t=LH

Benzinga Posted - 10/24/24

Laboratory Corp Q3 Earnings Beat Street View, Investors Overlook Hurricane Helene Impact https://www.benzinga.com/analyst-ratings/analyst-color/24/10/41522452/laboratory-corp-q3-earnings-beat-street-view-investors-overlook-hurricane-helene-im $LH $DGX

RallyRaider Posted - 10/24/24

$LH think much more coming

shorttingmaster Posted - 10/24/24

$LH break out, next target 260

DonCorleone77 Posted - 10/24/24

$LH Labcorp narrows FY24 adjusted EPS view to $14.30-$14.70 from $14.30-$14.90 Consensus $14.56. Narrows FY24 revenue view to 6.6%-7.7% from 6.4%-7.5%. The company said, "Labcorp is updating 2024 full year guidance to reflect its third quarter performance and full year outlook. The following guidance assumes foreign exchange rates effective as of September 30, 2024, for the remainder of the year. Enterprise level guidance includes the estimated impact from currently anticipated capital allocation, including acquisitions, share repurchases and dividends."

DonCorleone77 Posted - 10/24/24

$LH Labcorp reports Q3 adjusted EPS $3.50, consensus $3.48 Reports Q3 revenue $3.28B, consensus $3.26B. "Labcorp achieved strong performance in Diagnostics and Biopharma Laboratories, including robust organic growth in the third quarter," said Adam Schechter, chairman and CEO of Labcorp. "Our results demonstrate momentum in our core businesses as we introduced new tests, and extended our leadership position in specialty testing. We announced or completed several transactions with health systems and regional/local laboratories, which aligns with our acquisition strategy. We are on track to finish 2024 with strong growth as we focus on science, technology, and innovation and bring new tests and services to our customers."

DonCorleone77 Posted - 1 month ago

$FTRE $LH Activist Corvex acquires stake in Fortrea Holdings, Bloomberg reports Corvex Management has acquired a stake in Fortrea Holdings (FTRE), the clinical trials business that was spun out off Labcorp (LH), Bloomberg's Crystal Tse and Yiqin Shen report. Corvex CIO Keith Meister claims that the company could be worth $25-$27 per share once it improves its EBITDA margin, the authors note, citing a presentation at the 13D Monitor Active Passive Investor Summit. The activist investor added that Fortrea should weigh selling non-core assets, the authors say.

WeeklyTrader Posted - 1 month ago

Let’s discuss the headwinds for $LH! RSI: 45.23% 50-day MA: $223.37 200-day MA: $214.65

WeeklyTrader Posted - 1 month ago

What’s the scoop on $LH? Should we be worried? RSI: 44.31% 50-day MA: $223.76 200-day MA: $214.7

WeeklyTrader Posted - 1 month ago

gher with $LH!

Stocksrunner Posted - 09/27/24

As we wrap up the week, several companies have caught our attention with strong buy ratings based on current market analysis and performance indicators: $THC (Tenet Healthcare) continues to impress with an 118.2% gain in 2024, $LH (Laboratory Equipment) shows strong potential as the refurbished market expands, and $HTHT (H World Group) has crossed above the 200-day moving average, indicating solid momentum. These stocks are positioned for growth—stay informed! https://stocksrunner.com/

Stocksrunner Posted - 09/26/24

Thursday Pre-Market Tease: Something's Stirring... $HURA Kintara Therapeutics is strutting with a 110% pre-market pop. Why? Oh, just a little partnership with Beckman Coulter that could shake up life sciences. $LH Labcorp isn’t one to be left behind—buzzing early after its own Beckman Coulter collab. Something’s brewing, and it’s catching eyes. $TBIO Telesis Bio is playing along, riding the same Beckman Coulter wave. Surprised? You shouldn’t be. Let’s see who really owns the day when the bell rings. Stay tuned.

Stock_Titan Posted - 09/24/24

$LH Labcorp to Announce Third Quarter Financial Results on October 24, 2024 https://www.stocktitan.net/news/LH/labcorp-to-announce-third-quarter-financial-results-on-october-24-3mfr9gv9l4kl.html

ChristaBoarts Posted - 1 month ago

$LH remains a key player in the healthcare diagnostics space. Solid financials and innovative technology drive its growth. Powered by FAAS

Stock_Titan Posted - 2 months ago

$LH Ovia Health Expands Women's Health Offerings with Comprehensive Postpartum Experience https://www.stocktitan.net/news/LH/ovia-health-expands-women-s-health-offerings-with-comprehensive-460nv9c03mfh.html

tlivian Posted - 2 months ago

@Esau815 from a product perspective what do you think? I did some digging and $PMD is mighty proud of their patented process, but employers don't seem to care as much about that distinction. Labs like $DGX and $LH offer similar services and have partnered with different labs, while also offering the more common urine drug test. Do you think with that annual savings of not being a public company they can make a dent or with the issues with trying to be a public company they were stretched too thin or possibly sandbagging to buy the company for a song?

Stock_Titan Posted - 2 months ago

$LH $OPK Labcorp Completes Acquisition of Select Assets of BioReference Health's Diagnostics Business from OPKO Health https://www.stocktitan.net/news/LH/labcorp-completes-acquisition-of-select-assets-of-bio-reference-2ch9kt0odt5b.html

Aigner_Andreas Posted - 2 months ago

TD BUY $LH at 221.13, Supp 218.29 Resis 230.70 R6 HiLo 67% T1Y 293 buy 1.9 DIV 1.25% #Laboratory #stocks #trading #finance #market

LauriceGeel Posted - 2 months ago

$LH LabCorp’s leadership in diagnostics and laboratory services offers strong growth potential as healthcare demand rises, particularly in diagnostics and research. Check out my website, link in bio.

dontfeedthebashers Posted - 2 months ago

$LH

IN0V8 Posted - 2 months ago

$LH Opportunity Baird raises target price to $278 from $277

QuiverQuant Posted - 2 months ago

CONGRESSIONAL TRADING: Representative John James disclosed a purchase of $1,001 - $15,000 of $LH on 2024-09-02.

QuiverQuant Posted - 2 months ago

CONGRESSIONAL TRADING: Representative John James disclosed a sale of $1,001 - $15,000 of $LH on 2024-09-02.